Incentive Plans (Tables)
|
12 Months Ended |
Jan. 03, 2026 |
|---|
| Incentive Plans |
|
| Schedule of non-vested performance share LTIAs |
| | | | | | | | | | Weighted Average | | | Number of | | Grant Date Fair Value | | | Performance Shares (1) | | (per share)(2) | Beginning of fiscal 2025 | | 2,684,106 | | $ | 12.03 | Granted | | 2,321,319 | | $ | 4.44 | Vested | | — | | $ | — | Forfeited | | (627,314) | | $ | 14.21 | End of fiscal 2025 | | 4,378,111 | | $ | 7.69 |
| (1) | Solely for purposes of this table, the number of performance shares is based on the participants earning the maximum number of performance shares (i.e., 300.000% of the target number of performance shares). |
| (2) | The fair value of the awards was determined based upon the closing price of our common stock on the applicable measurement dates (i.e., the deemed grant dates for accounting purposes) reduced by the present value of expected dividends using the risk-free interest-rate as the award holders are not entitled to dividends or dividend equivalents during the vesting period. |
|
| Schedule of restricted stock activity |
| | | | | | | | | | Weighted Average | | | Number of Shares | | Grant Date Fair Value | | | of Restricted Stock | | (per share)(1) | Beginning of fiscal 2025 | | 689,137 | | $ | 12.86 | Granted | | 767,569 | | $ | 6.60 | Vested | | (390,582) | | $ | 12.22 | Forfeited | | (10,454) | | $ | 9.91 | End of fiscal 2025 | | 1,055,670 | | $ | 8.58 |
| (1) | The fair value of the awards was determined based upon the closing price of our common stock on the applicable measurement dates (i.e., the deemed grant dates for accounting purposes). |
|
| Schedule of stock option activity |
The following table details our stock option activity for fiscal 2025 (dollars in thousands, except per share data): | | | | | | | | | | | | | | | Weighted | | Weighted Average | | | | | | | Average | | Contractual Life | | Aggregate | | | Options | | Exercise Price | | Remaining (Years) | | Intrinsic Value | Outstanding at beginning of fiscal 2025 | | 1,773,573 | | $ | 24.35 | | 6.70 | | $ | — | Granted | | 398,647 | | $ | 4.15 | | | | | | Exercised | | — | | $ | — | | | | | | Forfeited | | — | | $ | — | | | | | | Expired | | (66,027) | | $ | 30.63 | | | | | | Outstanding at end of fiscal 2025 | | 2,106,193 | | $ | 20.33 | | 6.56 | | $ | 20 | Exercisable at end of fiscal 2025 | | 807,546 | | $ | 28.23 | | 4.57 | | $ | — |
|
| Schedule of stock options, valuation assumption |
| | | | | | | Fiscal 2025 | | Fiscal 2024 | Weighted average grant date fair value | $ | 0.41 | | $ | 2.32 | Expected volatility | | 53.8% | | | 48.2% | Expected term | | 5.5 years | | | 5.5 years | Risk-free interest rate | | 4.1% | | | 4.4% | Dividend yield | | 18.3% | | | 7.9% |
|
| Schedule of number of shares of common stock issued by entity upon the vesting of performance share long-term incentive awards other share based compensation |
| | | | | | | | | | | | Fiscal 2025 | | Fiscal 2024 | | Fiscal 2023 | Number of performance shares vested | | | — | | | — | | | 360,926 | Shares withheld for tax withholding | | | — | | | — | | | (131,803) | Shares of common stock issued for performance share LTIAs | | | — | | | — | | | 229,123 | Shares of common stock issued upon the exercise of stock options | | | — | | | — | | | — | Shares of common stock issued to non-employee directors for annual equity grants | | | 222,003 | | | 116,532 | | | 81,531 | Shares of restricted common stock issued to employees | | | 767,569 | | | 479,746 | | | 329,821 | Shares of restricted stock cancelled for tax withholding upon vesting | | | (146,868) | | | (54,668) | | | (14,448) | Shares of restricted stock cancelled upon forfeiture | | | (10,454) | | | (21,229) | | | (2,598) | Net shares of common stock issued | | | 832,250 | | | 520,381 | | | 623,429 |
|
| Schedule of compensation expense recognized for share-based payments |
The following table sets forth the compensation expense recognized for share-based payments (performance share LTIAs, restricted stock, stock options, non-employee director stock grants, and other share-based payments) during the last three fiscal years and where that expense is reflected in our consolidated statements of operations (in thousands): | | | | | | | | | | | | Fiscal 2025 | | Fiscal 2024 | | Fiscal 2023 | Compensation expense included in cost of goods sold | | $ | 1,347 | | $ | 960 | | $ | 633 | Compensation expense included in selling, general and administrative expenses | | | 11,970 | | | 7,704 | | | 6,558 | Total compensation expense for share-based payments | | $ | 13,317 | | $ | 8,664 | | $ | 7,191 |
|